Source · Select Committees · Women and Equalities Committee
Recommendation 22
22
Deferred
Implement policies ensuring separate spaces for reproductive health and obstetrics patients during investigations/treatment
Conclusion
NHS England should implement policies to ensure there are separate spaces for patients undergoing investigations or treatment for reproductive health conditions and obstetrics patients. (Paragraph 91) Waiting lists
Government Response Summary
The government's response did not address the recommendation for separate spaces for reproductive health and obstetrics patients. Instead, it discussed the diagnosis of Polycystic Ovary Syndrome (PCOS), including the potential role of AMH blood tests and NICE's planned clinical guideline on PCOS.
Government Response
Deferred
HM Government
Deferred
Polycystic ovary syndrome ( PCOS ) is a complex syndrome characterised by: multiple follicles in the ovary menstrual irregularity high testosterone levels Diagnosis is typically made using a combination of: medical history blood tests ultrasound scans While the anti-mullerian hormone ( AMH ) blood test may have potential, there would need to be further exploration of how it could add value in the diagnosis of PCOS . NHS England would first need to work with NICE to evaluate its impact on quality of care and cost-effectiveness to determine whether its broader implementation should be recommended. NICE has been asked to develop a clinical guideline on the assessment and management of PCOS and is now planning its development. Work in this area will include the diagnosis of PCOS , including consideration of AMH blood tests. NICE is exploring the possibility of collaboration with a reputable guidance-producing partner to enhance the speed and efficiency of this work. The progress of this guideline can be followed at Polycystic ovary syndrome: diagnosis and management .